Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2009
-
By Kevin E. Noonan — Today, the Senate Judiciary Executive Committee continued its Executive Business Meeting from last week and announced that "significant" progress had been made in reaching a compromise on S. 515 supported by Committee Chairman Senator Patrick Leahy (D-VT), ranking member Senator Arlen Spector (R-PA), and Senator Diane Feinstein (D-CA) (a…
-
By Kevin E. Noonan — The duality of nucleic acids has long posed a challenge to patent law. A gene is, in one way of looking at it, "but a chemical compound, albeit a complex one," and this view of the gene's nature has informed the emphasis on "structure, structure, structure" taken by the…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Monsanto Co. et al. v. Dart et al.4:09-cv-00474; filed March 25, 2009 in the Eastern District of Missouri Infringement of U.S. Patent…
-
March 30-31, 2009 – Pharmaceutical and Biotech Patent Claim Drafting*** (American Conference Institute) – New York, NY March 30-31, 2009 – FDA Boot Camp*** (American Conference Institute) – New York, NY April 1-4, 2009 – 24th Annual Intellectual Property Law Conference (American Bar Association Section of Intellectual Property Law) – Arlington, VA April 16, 2009…
-
The Biotechnology Industry Organization (BIO) will be holding its annual BIO International Convention on May 18-21, 2009 in Atlanta, GA. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,200 biotechnology companies, state and international affiliates, and related organizations, as well as providing business development services for…
-
By Christopher P. Singer — One of our European associates, Forresters, alerted us today about change to Rule 36 EPC that was enacted on March 26, 2009 by the EPO Administrative Council. The rule change is expected to limit the opportunities for divisional application filings in Europe, relative to the current rule, in an…
-
The Biotech Committee of the Intellectual Property Law Association of Chicago (IPLAC) will be hosting its next Biologue Chicago event on April 16, 2009 from 5:30-7:30 pm at the Metropolitan Club in the Sears Tower (now known to some as the Willis Tower). Biologue Chicago, which was launched by the Biotech Committee of the IPLAC…
-
By Christopher P. Singer — The Senate Judiciary Committee held an Executive Business Meeting today to discuss, among other topics, the pending Patent Reform Bill, S. 515. The recorded meeting can be viewed here. [Note: the portion relating to S. 515 begins just after the 11 minute mark]. Most of the discussion relating to…
-
On Wednesday, we reported on an article, entitled "The dangers of diagnostic monopolies," that appeared in the March 26th edition of Nature (see "Genetic Diagnostic Testing: The 'Anti-Commons' Revisited?"). Today, we received an e-mail from one of the authors of the article, Robert Cook-Deegan (at right), providing some additional comments regarding the article: This is…
-
By Christopher P. Singer — The Intellectual Property Owners Association (IPO) today announced that its Board of Directors has adopted two resolutions, one against any legislation concerning willful patent infringement, and the other against any significant U.S. Patent and Trademark Office fee increases for fiscal year 2009. In its daily e-mail letter, the IPO…
Patent Docs 